反応式
[CH2:1]([O:4][C:5]1[N:10]=[C:9]([C:11]([OH:13])=O)[CH:8]=[N:7][C:6]=1[N:14]1[CH2:18][CH2:17][CH2:16][CH2:15]1)[CH2:2][CH3:3].CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CCN(C(C)C)C(C)C.[NH2:50][C@@H:51]([CH2:54][CH:55]([CH3:57])[CH3:56])[CH2:52][OH:53]>CN(C=O)C.C(O)=O>[OH:53][CH2:52][C@@H:51]([NH:50][C:11]([C:9]1[CH:8]=[N:7][C:6]([N:14]2[CH2:18][CH2:17][CH2:16][CH2:15]2)=[C:5]([O:4][CH2:1][CH2:2][CH3:3])[N:10]=1)=[O:13])[CH2:54][CH:55]([CH3:57])[CH3:56]参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
A mixture of 6 mg (0.024 mmol) 6-propoxy-5-pyrrolidin-1-yl-pyrazine-2-carboxylic acid, 9.3 mg (0.029 mmol) TBTU, 9.3 mg (0.072 mmol) DIPEA and 4.2 mg (0.036 mmol) (S)-2-amino-4-methyl-pentan-1-ol (commercially available) in 1 mL DMF was shaken at room temperature for 16 h. After addition of formic acid the mixture was subjected to purification by preparative HPLC on reversed phase eluting with a gradient formed from acetonitrile, water and formic acid. The combined product fractions were evaporated to yield 2 mg (24%) of the title compound. m/z (ES+): 351.5 (M+H).
後処理
- customwas subjected to purification by preparative HPLC on reversed phase
- washeluting with a gradient
- customformed from acetonitrile, water and formic acid
- customThe combined product fractions were evaporated
出典と根拠
- ORDレコード
- ord-13572c0ed70f480daa3350330e68eace
- 出典データセット
- uspto-grants-2010_04
- 特許番号
- US07691863B2
関連ノート
読み込み中…